What is Darktrace?
Founded in 2013 and headquartered in Cambridge, United Kingdom, Darktrace operates as a pioneer in the artificial intelligence sector, specifically targeting the cyber defense market. The company provides an enterprise immune system that utilizes unsupervised machine learning to detect and respond to cyber-attack vectors in real-time. By moving beyond traditional signature-based security, Darktrace offers a sophisticated, behavioral-based approach that protects cloud, network, and enterprise environments. Its market position is defined by its ability to autonomously neutralize threats, making it an essential component of modern digital infrastructure for organizations worldwide.
How much funding has Darktrace raised?
Darktrace has raised a total of $459.5M across 6 funding rounds:
Series A
$18M
Series B
$22.5M
Series C
$64M
Series D
$75M
Series E
$50M
Share Placement
$230M
Series A (2015): $18M with participation from Talis Capital, Invoke Capital, and Hoxton Ventures
Series B (2015): $22.5M led by Summit Partners
Series C (2016): $64M supported by SoftBank Corp, Invoke Capital, Summit Partners, TenEleven Ventures, and KKR
Series D (2017): $75M featuring KKR & Co. L.P, Summit Partners, TenEleven Ventures, and Insight Venture Partners
Series E (2018): $50M backed by Vitruvian Partners, KKR, and 1011 Ventures
Share Placement (2021): $230M, investors not publicly disclosed
Key Investors in Darktrace
Invoke Capital
Invoke Capital specializes in founding and advising fast-growing European technology companies, particularly in artificial intelligence, leveraging deep academic connections to commercialize advanced research.
KKR
KKR is a global investment firm that invests across private markets, focusing on fortifying companies and driving long-term value through operational expertise.
Summit Partners
Summit Partners is an established equity investment firm that provides growth capital to entrepreneurial companies, supporting their scaling efforts through strategic financial backing.
What's next for Darktrace?
With a robust history of capital infusion, Darktrace is well-positioned to further its technological edge in the competitive cybersecurity arena. The company's strategic focus remains on expanding its AI-driven capabilities to address increasingly complex threat landscapes. As it continues to mature, the firm is likely to prioritize global market penetration and the enhancement of its Antigena product suite. The ongoing support from high-conviction investors suggests a long-term commitment to maintaining Darktrace's status as a leader in autonomous cyber defense, ensuring that the company remains at the forefront of the information security revolution.
See full Darktrace company page
